Author

Robin Apblett

Observed name: R. Apblett

OpenAlex ID: A5035972006

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

2003 · Douglas Burtrum, Zhenping Zhu, et al. · PubMed · 348

285 Degradation of the epidermal growth factor receptor occurs upon cetuximab treatment

2004 · J. Doody, Y. Wang, et al. · European Journal of Cancer Supplements

Works count: 2

Citation count: 348

H-index: 1

I10-index: 1